Investigators have developed a prognostic model that may identify which patients with MIBC are suitable for bladder-preserving chemoradiation.

Stage 2 cervical cancer is classified into 2A and 2B, based on tumor spread and size, affecting treatment decisions.

A daily pill called osimertinib (Tagrisso) is delivering far longer cancer control for adults with unresectable stage 3 EGFR-mutated non-small cell lung cancer after chemoradiation and is now ...

Stage 2 oral cavity cancer involves tumors larger than 2 cm but not exceeding 4 cm, without lymph node or distant spread. Diagnosis includes physical exams, biopsies, imaging tests, and endoscopy to ...

Experts explore the messy intersection between evidence-based cancer care and an enticing wellness industry dominated by ...

Cancer has evolved to protect itself from our inherent immune responses, and some types of cancer cells have developed their own strategies to evade or withstand treatment. These pro-cancer shields ...

Tiragolumab plus atezolizumab does not improve survival compared to durvalumab in locally advanced, unresectable, stage 3 NSCLC.

Regeneron Canada Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by public drug programs in Ontario, British Columbia, Saskatchewan, Nova Scotia, Newfoundland and ...

Announced intent to separate biopharma operations from substantial royalty assets by YE 2026Phase 2 top-line data through Week 12 for rosnilimab, ...

Regeneron Canada Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by Régie de l'assurance maladie du Québec (RAMQ) in Québec for adults with advanced non-small cell ...